Is Lexaria Bioscience Corp. (LEXX) A Good Stock To Buy?
The latest 13F reporting period has come and gone, and Insider Monkey is again at the forefront when it comes to making use of this gold mine of data.
Lexaria Bioscience Corp. (LEXX)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Invenomic Capital Management Ali Motamed | 475,773 | $1,451,108 | -8% | 0.07% |
| 2. | Armistice Capital Steven Boyd | 0 | $0 | -100% | 0% |
| 3. | ADAR1 Capital Management Daniel Schneeberger | 0 | $0 | -100% | 0% |
| 4. | Renaissance Technologies Jim Simons | 0 | $0 | -100% | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $3.13 | 1,600 | Director | 3,100 | 2024-08-12 | Filing | |
| $2.84 | 1,500 | Director | 1,500 | 2023-02-09 | Filing | |
| $2.09 | 121 | Officer | 1,954 | 2022-10-14 | Filing | |
| $2.10 | 16,600 | Officer, Director | 254,412 | 2022-10-13 | Filing | |
| $1.99 | 21,900 | Officer, Director | 237,812 | 2022-10-12 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $4.00 | 2,567 | Officer | 0 | 2024-07-31 | Filing | |
| $1.90 | 2,100 | Director | 285,738 | 2018-05-31 | Filing | |
| $1.91 | 100 | Director | 287,838 | 2018-05-30 | Filing | |
| $1.90 | 47,800 | Director | 287,938 | 2018-05-30 | Filing | |
| $0.35 | 700 | Officer | 250,385 | 2010-12-22 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 256,327 | $320,408 | 0.02% | |
| 2. | 78,950 | $98,688 | 0% | |
| 3. | 53,592 | $67,028 | 0% | |
| 4. | 46,241 | $57,801 | 0% | |
| 5. | 41,651 | $18,743 | 0.03% |
News See All
